>
Kick-Off Meeting, Krakow, Poland
27-03-2023
The EUthyroid2 kick-off meeting was held on 27-29th March 2023 in Krakow, Poland. All consortium members presented their organisations and roles in the project. This two-day meeting offered an overview of the work packages and an outline of detailed plans.
The representatives of the project partner institutions met with other consortium members to align on the next steps for increasing awareness of iodine deficiency disorders (IDD) and related risks among adolescents and young women in Europe and beyond.
The project builds on EUthyroid and the Krakow Declaration on iodine and will establish best practice models for cost-effective, sustainable prevention of IDD across EU member states.
Professor Henry Völzke (University Medicine Greifswald), the scientific coordinator of the EUthyroid2 project, identified the project aims. All work package leaders outline their road map for the activities of the first year of the project to the consortium.
The project participants and partners are committed to taking important steps toward the elimination of iodine deficiency and preventable iodine-related disorders in Europe and beyond.
>
Second Annual Meeting, Baveno, Italy
09-10-2024
The Second Annual Meeting of the EUthyroid2 project was held on the 9th of October, 2024, in Baveno, Italy. The meeting offered an excellent opportunity for the work packages to present the progress achieved and give an outline of tasks ahead.
The Advisory Board Members participated in the meeting online: Prof. Dr. Heather Foran, the Coordinator of EUthyroid2 sister project, FLOURISH Study, Prof. Christa Meisinger, MD, MPH, Epidemiologist, University of Augsburg, and Prof. Dr. Leonidas Duntas, Endocrinologist, Evgenidion Hospital, University of Athens, offered valuable insights and advice to the consortium.
The day began with an inspiring session by Prof. Henry Völzke, Coordinator of the EUthyroid2 project, who gave an overview of the broader aims for the upcoming year. The meeting progressed with presentations on the study implementation in the ambulatory care and educational settings by Vivien Henck, University Medicine Greifswald, Theresa Heering, Heinrich Heine University Düsseldorf, Signe Skovgaard Hansen, Technical University of Denmark, and Synnøve Næss Sleire, Institute of Marine Research.
Christoph Schickhardt, Ethics Advisor, discussed the question of ethical challenges in the intervention, while Phil Pendt, University Medicine Greifswald summarised the structure of the intervention materials.
Anna Bokor, TFI, gave an overview of the communication and dissemination activities and study materials in different languages.
Through educational and ambulatory care interventions, EUthyroid2 aims to increase awareness among adolescents and young people about the risks of iodine deficiency and the importance of iodine for their health and that of their future offspring.
The project participants and partners are committed to taking important steps toward the elimination of iodine deficiency and preventable iodine-related disorders in Europe and beyond.